Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
Clinical trial NCT00961090 · COMPLETED
Trial details
- NCT number
- NCT00961090
- Sponsor
- Matthew R Quigley
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2015-04-22
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.